Biomm Company Description

Biomm S.A. operates as a biotechnology company in Brazil.

The company offers AFREZZA, a human insulin inhalation powder; GHEMAXAN, an enoxaparina sodica; GLARGILIN, a glargine insulin; WOSULIN R, a human insulin; WOSULIN N, an isophane insulin; HERZUMA, a trastuzumab; and CANETA LIFEPEN G PARA APLICACAO DE INSULINA.

Biomm S.A. was founded in 2001 and is headquartered in Nova Lima, Brazil.

Biomm S.A.

Country	Brazil
Founded	2001
Industry	Biotechnology
Sector	Healthcare
Employees	130
CEO	Heraldo Marchezini

Contact Details

Address: 705 – Lagoa dos Ingleses Nova Lima, 34018-000 Brazil
Phone	55 31 3299 1000
Website	biomm.com

Stock Details

Ticker Symbol	BIOM3
Exchange	Brazil Stock Exchange
Fiscal Year	January - December
Reporting Currency	BRL
ISIN Number	BRBIOMACNOR2
SIC Code	2836

Key Executives

Name	Position
Heraldo Carvalho Marchezini	Chief Executive Officer and Member of The Executive Board
Renato Arroyo Barbeiro	Financial Director, IR and Member of Executive Board
Francisco Carlos Marques de Freitas	Chief Operating Officer and Member of The Executive Board
Francisco Rafael Costa Jr.	Commercial Director and Member of Executive Board
Nayara Rodrigues de Souza Cruz	Accountant
Mara Bertolin dos Santos Gomes	Controller